Solid Biosciences SLDB

$ 7.06 -2.89%

Quarterly report 2024-Q2
added 08-13-2024

Solid Biosciences Balance Sheet 2011-2024 | SLDB

Annual Balance Sheet Solid Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-70.9 M	-152 M	-118 M	-	-69 M	-85.3 M	-52.1 M	-7.68 M	-28.6 M	-	-	-	-
Long Term Debt	1.23 M	1.7 M	275 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.86 M	1.9 M	1.26 M	2 M	1.74 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	5.15 M	1.93 M	124 M	71.6 M	61.7 M	-	-	-	-
Total Current Liabilities	14.5 M	22.5 M	23.6 M	24.5 M	18.3 M	12.5 M	-	-	-	-	-	-	-
Total Liabilities	38.5 M	48.6 M	24.2 M	39.1 M	23.4 M	14.4 M	135 M	78.5 M	75.6 M	-	-	-	-
Deferred Revenue	-	-	-	10.4 M	-	-	-	-	-	-	-	-	-
Retained Earnings	-659 M	-563 M	-477 M	-405 M	-316 M	-199 M	-124 M	-84.9 M	-67.7 M	-	-	-	-
Total Assets	165 M	260 M	232 M	171 M	103 M	140 M	76.2 M	40.6 M	55.7 M	-	-	-	-
Cash and Cash Equivalents	74 M	155 M	119 M	155 M	76 M	86.4 M	52.1 M	7.84 M	-	-	-	-	-
Book Value	126 M	212 M	208 M	132 M	80 M	125 M	-59.3 M	-37.9 M	-19.9 M	-	-	-	-
Total Shareholders Equity	126 M	212 M	208 M	132 M	80 M	125 M	-59.3 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Solid Biosciences

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	953 K	1.1 M	1.23 M	23.2 M	23.6 M	23.9 M	24.3 M	-	24.5 M	231 K	293 K	353 K	412 K	469 K	525 K	525 K	525 K	525 K	733 K	733 K	733 K	733 K	859 K	859 K	859 K	859 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	23 M	-	23.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	37.7 M	38 M	38.5 M	40.4 M	41 M	45.8 M	48.6 M	41.2 M	46.3 M	22 M	24.2 M	25.6 M	27.9 M	32.3 M	39.1 M	39.1 M	39.1 M	39.1 M	23.4 M	23.4 M	23.4 M	23.4 M	14.4 M	14.4 M	14.4 M	14.4 M	11.3 M	11.3 M	11.3 M	11.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	6.17 M	8.08 M	8.86 M	10 M	10.7 M	10.4 M	10.4 M	10.4 M	10.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-708 M	-683 M	-659 M	-638 M	-617 M	-593 M	-563 M	-548 M	-527 M	-502 M	-477 M	-458 M	-440 M	-421 M	-405 M	-405 M	-405 M	-405 M	-316 M	-316 M	-316 M	-316 M	-199 M	-199 M	-199 M	-199 M	-124 M	-124 M	-124 M	-124 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	231 M	249 M	165 M	185 M	205 M	230 M	260 M	184 M	208 M	208 M	232 M	249 M	266 M	285 M	171 M	171 M	171 M	171 M	103 M	103 M	103 M	103 M	140 M	140 M	140 M	140 M	76.2 M	76.2 M	76.2 M	76.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	95.9 M	118 M	74 M	49 M	91.6 M	165 M	155 M	48.8 M	54.3 M	130 M	119 M	110 M	201 M	268 M	155 M	155 M	155 M	155 M	76 M	76 M	76 M	76 M	86.4 M	86.4 M	86.4 M	86.4 M	52.1 M	52.1 M	52.1 M	52.1 M	7.68 M	-	-	-	28.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	193 M	211 M	126 M	144 M	164 M	184 M	212 M	143 M	162 M	186 M	208 M	223 M	238 M	253 M	132 M	132 M	132 M	132 M	80 M	80 M	80 M	80 M	125 M	125 M	125 M	125 M	64.9 M	64.9 M	64.9 M	64.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	193 M	211 M	126 M	144 M	164 M	184 M	212 M	143 M	162 M	186 M	208 M	223 M	238 M	253 M	132 M	132 M	132 M	132 M	80 M	80 M	80 M	80 M	125 M	125 M	125 M	125 M	-59.3 M	-59.3 M	-59.3 M	-59.3 M	-37.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency